Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 12,200

Document Document Title
WO/2019/012406A1
The present invention is directed to Clostridium difficile toxin-specific antibodies, compositions, and uses thereof. The anti-toxin antibodies may be specific for TcdA. The invention also includes methods of treating a Clostridium diffi...  
WO/2019/011852A1
This invention relates to agents that bind human Siglecs having inhibitory activity in immune cells, and that neutralize the inhibitory activity of such Siglec. Such agents can be used for the treatment of cancers.  
WO/2019/003963A1
[Problem] To provide a singlet oxygen scavenger having high singlet oxygen scavenging ability. [Solution] This singlet oxygen scavenger contains, as active ingredients, benzyl diethylaminohydroxybenzoylbenzoate, 1-(4-methoxyphenyl)-3-(4-...  
WO/2018/229218A1
The present disclosure relates to novel dosage regimes for the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to novel dosage regimes for the admi...  
WO/2018/229222A1
The present disclosure relates to the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to administration of ADCs which bind to CD19 (CD19-ADCs).  
WO/2018/225790A1
The present application discloses a crystal of an oxidized glutathione dication salt and a production method for the crystal.  
WO/2018/223417A1
Provided are a Bacillus subtilis BS16 with cephalosporin resistance and high expression of Sir2 protein and an application thereof. The Bacillus subtilis BS16 with cephalosporin resistance and high expression of Sir2 protein can enhance ...  
WO/2018/218694A1
Provided are a Bifidobacterium longum BL16 having cephalosporin resistance and high expression of Sir2 protein, and application thereof in preparing foods or medicines for anti-aging, enhancing immune function, or regulating intestinal m...  
WO/2018/220428A1
The main objective of the present invention is to develop an herbal formulation with high polyphenol concentrations. A therapeutic effect of ingredients in herbal composition with Antioxidants, Anti-inflammatories, Anti Viral & Anti Micr...  
WO/2018/218693A1
Provided are a Lactobacillus acidophilus LA17 having cephalosporin resistance and high expression of Sir2 protein, and application thereof in preparing foods or medicines for anti-aging, enhancing immune function, or regulating intestina...  
WO/2018/213204A1
The present disclosure provides methods and compositions for the prevention, amelioration, or alleviation of one or more neurological disorders associated with microbially- induced amyloid formation. Methods of inhibiting, ameliorating, ...  
WO/2018/212152A1
[Problem] To provide an ophthalmic composition that is efficacious for preventing or treating myopia or ophthalmic diseases. In particular, to provide: an ophthalmic composition that is efficacious for growing children and young adults, ...  
WO/2018/208138A1
Herbal composition comprising composition of the extract from combined plant materials in appropriate percentages based on the total weight of the mixture wherein the plant materials are selected from the group consisting of Sage (Salvia...  
WO/2018/205191A1
An industrial preparation method suitable for extracting four types of quassin ingredient from eurycoma longifolia plants, and an application for preparing products. Ultrasonic countercurrent water extraction and silica gel-low boiling p...  
WO/2018/207790A1
Provided is a highly safe and sustainably ingestible agent for promoting decomposition and excretion of amyloid-β. The agent for promoting decomposition and excretion of amyloid-β contains a chlorogenic acid or a salt thereof as an act...  
WO/2018/207810A1
Provided are: a method for producing an extract or the like which contains a large amount of a component more useful for an anti-aging effect than a conventional placenta-derived raw material, wherein the extract or the like is produced ...  
WO/2018/203774A1
The invention relates to the pharmaceutical industry and to medicine, in particular to a medicinal composition in the form of an aqueous solution that has a cytoprotective effect and contains as the active components: dimeglumine succina...  
WO/2018/202882A1
The present invention relates to a iodinated contrast medium (ICM), for use as a medicament for preventing radioactive iodine uptake by the thyroid gland after a nuclear accident. The ICM can advantageously be administered via the sublin...  
WO/2018/204153A1
The invention generally relates to compositions and methods for treating snake envenomation in animals, including humans. In some aspects, the invention provides therapeutic compositions that contain one or more toxin binding molecules i...  
WO/2018/197394A1
The present invention relates to systemic detoxification by using extracts of Withania somnifera (ashwagandha) and its Nrf2-activating components withaferin-A, 12- deoxywithastramonolide, and Quresimine A. When ingested, the transcriptio...  
WO/2018/191771A1
The invention relates to a method of preventing or treating a congenital malformation in an unborn offspring of a subject, the method comprising administering to the subject a therapeutically effective amount of NAD or an intermediate of...  
WO/2018/191789A1
The invention relates to compounds of Formula (I) and methods for their preparation. Also described are pharmaceutical compositions comprising a compound of Formula (I) and their use in the treatment or prevention of conditions associate...  
WO/2018/187852A1
Compositions and methods for providing a person with an exogenous and therapeutically effective supply of ketones are disclosed. The compositions may consist essentially of (a) purified butyrate (or esters or propionate salts thereof) an...  
WO/2018/188525A1
A composition for use in improving circulation in the body and delaying aging, as well as a use thereof; said composition is made by using Rosa roxburghii Tratt., Phyllanthus emblica, honey, walnut, and lemon as raw materials.  
WO/2018/185348A1
The invention relates to a pharmaceutical composition based on a highly pure aqueous solution of chlorine dioxide for use in the local or systemic treatment of acute intoxication caused by toxic substances from plants, mushrooms, aquatic...  
WO/2018/181987A1
Provided is an adsorbent for indole and derivatives thereof that selectively adsorbs indole and derivatives thereof (particularly indole). A copolymer synthesized by mixing structural units based on each monomer at an optimal ratio was d...  
WO/2018/181345A1
Provided is a compound which has an Nrf2-activating activity and is expected to be useful as a prophylactic or therapeutic agent for diseases associated with oxidative stress, particularly hepatitis (e.g., non-alcoholic steatohepatitis (...  
WO/2018/172998A1
The invention provides a composition rich in flavonoids based on natural extracts, comprising a flavonoid extract dispersed by melt mixing or extrusion and encapsulated in a polymer matrix. The invention is also a novel dietary supplemen...  
WO/2018/169055A1
It is known that foods containing a carbohydrate, e.g., starch, in a large amount generate acrylamide upon heating at high temperatures. Some documents state that acrylamide is formed by the Maillard reaction of an amino acid, e.g., aspa...  
WO/2018/170410A1
The disclosure provides chemical compounds possessing therapeutic and/or protective properties against oxidative damage. Methods of making such therapeutic and/or protective compounds and associated compositions are also provided, as are...  
WO/2018/165780A1
Compositions comprising oil palm phenolics and shikimic acid or derivatives thereof and their use in enhancing anti-oxjdative and anti-inflammatory properties.  
WO/2018/162581A1
The present invention relates to desmethylanethole trithione ( AOX ) and derivatives thereof, especially derivatives of formula (I), for the prevention and treatment of diseases whose initiation and/or evolution relates to the production...  
WO/2018/159852A1
The purpose of the present invention is to provide a curcumin-containing solid composition which can be used as a composition for treatment or prevention of disorders or symptoms in which intracellular absorption of curcumin is beneficia...  
WO/2018/153334A1
The present invention provides a biflavonoid-nickel complex and a preparation method and application thereof. The present invention uses amentoflavone as a ligand and a nickel ion as a central ion for reaction to obtain an amentoflavone-...  
WO/2018/153325A1
Disclosed are a biflabonoid-cobalt complex, a preparation method for same, and applications thereof. The present invention has amentoflavone as a ligand and a cobalt ion as a central ion, produces an amentoflavone-cobalt complex via a re...  
WO/2018/153328A1
Disclosed are a biflavonoid-iron complex, a preparation method therefor and use thereof. In the present invention, the amentoflavone-iron complex is obtained by the reaction of the amentoflavone as a ligand and iron ions as central ions,...  
WO/2018/153330A1
Disclosed in the present invention are a biflavonoid-copper complex, a preparation method and an application thereof. In the present invention, amentoflavone is used as a ligand and a copper ion is used as a central ion, an amentoflavone...  
WO/2018/153333A1
The present invention provides a biflavonoid-manganese complex and a preparation method and application thereof. The present invention uses amentoflavone as a ligand and a manganese ion as a central ion for reaction to obtain an amentofl...  
WO/2018/153331A1
The invention discloses a biflavone-zinc complex as well as a preparation method therefor and a use thereof. The invention takes amentoflavone as a ligand, zinc ion as a central ion, and amentoflavone-zinc complex is obtained through rea...  
WO/2018/148788A1
The present invention relates to methods for predicting a risk and a rate of amyloid deposition and plaque formation which relates a correlation between brain iron load and amyloid deposition and plaque formation. The invention also rela...  
WO/2018/152283A1
Water-soluble nanoceria are described herein along with methods of making and using the same. Water-soluble nanoceria described herein comprise a cerium oxide nanoparticle and glycol chitosan. In some embodiments, water-soluble nanoceria...  
WO/2018/145664A1
A composition, comprising a first component --- Cistanche tubulosa extract and a second component --- an oxidized coenzyme (Q10) and/or a reduced coenzyme (QH). The weight ratio of the two components is: first component:second component=...  
WO/2018/145105A1
A method of diminishing the appearance of or effecting the removal or disappearance of seborrheic keratoses by the application of compositions containing a) one or more, preferably a combination of, dietary antioxidants and/or antioxidan...  
WO/2018/142328A1
The present invention relates to a composition comprising quercetin, prunus cerasus dry extract and vitamin C. The invention further relates to the use of the composition in maintaining the levels of uric acid and/or in the prevention an...  
WO/2018/140383A9
A composition for improving the health of a subject in a manner comparable to a bowl of homemade chicken soup is provided. The composition may include n-acetyl cysteine, vitamin C, and one or more carotenoids. The composition may be desi...  
WO/2018/139404A1
As a technique for effectively treating or preventing radiation sickness associated with exposure to radiation, a therapeutic or prophylactic agent for radiation sickness associated with exposure to radiation and others are provided, whe...  
WO/2018/140383A1
A composition for improving the health of a subject in a manner comparable to a bowl of homemade chicken soup is provided. The composition may include n-acetyl cysteine, vitamin C, and one or more carotenoids. The composition may be desi...  
WO/2018/134783A1
Described herein are methods for reducing the risks of exposure to air pollutants, comprising nasally administering to a subject in need thereof a composition that counteracts the effects of one or more air pollutants, wherein the compos...  
WO/2018/129411A1
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases o...  
WO/2018/124067A1
The present application provides: a radiation damage protective agent characterized by containing, as an active ingredient, hydrogen gas for treating or alleviating radiation damage suffered by a human patient who has experienced radiati...  

Matches 1 - 50 out of 12,200